DIASTAT Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Diastat, and when can generic versions of Diastat launch?

Diastat is a drug marketed by Bausch and is included in one NDA.

The generic ingredient in DIASTAT is diazepam. There are eight drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the diazepam profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Diastat

A generic version of DIASTAT was approved as diazepam by MYLAN on September 4^th, 1985.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DIASTAT?
What are the global sales for DIASTAT?
What is Average Wholesale Price for DIASTAT?

Summary for DIASTAT

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	68
Clinical Trials:	5
Patent Applications:	4,572
Drug Prices:	Drug price information for DIASTAT
What excipients (inactive ingredients) are in DIASTAT?	DIASTAT excipients list
DailyMed Link:	DIASTAT at DailyMed

Drug patent expirations by year for DIASTAT

Recent Clinical Trials for DIASTAT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Aquestive Therapeutics	Phase 1/Phase 2
Acorda Therapeutics	Phase 2
University of Minnesota	Phase 1

See all DIASTAT clinical trials

US Patents and Regulatory Information for DIASTAT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-001	Jul 29, 1997		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	DIASTAT ACUDIAL	diazepam	GEL;RECTAL	020648-006	Sep 15, 2005	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-004	Jul 29, 1997		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-002	Jul 29, 1997		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-003	Jul 29, 1997		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch	DIASTAT ACUDIAL	diazepam	GEL;RECTAL	020648-007	Sep 15, 2005	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for DIASTAT

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-001	Jul 29, 1997	⤷ Sign Up	⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-004	Jul 29, 1997	⤷ Sign Up	⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-005	Jul 29, 1997	⤷ Sign Up	⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-003	Jul 29, 1997	⤷ Sign Up	⤷ Sign Up
Bausch	DIASTAT	diazepam	GEL;RECTAL	020648-002	Jul 29, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for DIASTAT

See the table below for patents covering DIASTAT around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Canada	2171627	COMPOSITION ADMINISTREE PAR VOIE RECTALE, POUR EMPECHER LES CRISES D'EPILEPSIE (RECTALLY-ADMINISTERED, EPILEPTIC-SEIZURE-INHIBITING COMPOSITION)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	9507672		⤷ Sign Up
Australia	7686394		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for DIASTAT

Recent Clinical Trials for DIASTAT

Make Better Decisions: Try a trial or see plans & pricing